NEPH (Nephros) Enterprise Value-to-Revenue Coefficient

nephros.com (NEPH) - corporate logo

The EV-to-revenue multiple confirms the dominance of Nephros, Inc. (NEPH) in the clinic infection protection segment, where strict hygiene standards block dumping. The 1255.33 metric determines this valuation level. Nephros, Inc. (NEPH) leads in surgical water ultrafiltration and holds FDA approval. To optimize logistics and component production, the business relies on external contractors and contract manufacturing plants.

NEPH: Nephros EV/Sales Multiple 11/23/2025 - 11/20/2026

Nephros Corp - analytical breakdowns and key metrics (NEPH)

- share price and consensus valuation forecast:
- business market valuation indicators:
Initial company analysis:nephros.com NEPH
Brand item of Nephros Inc

Market expectations for Nephros, Inc. (NEPH) depend on the efficiency of implementing robotic lines and AI-driven quality control, which directly impacts future revenue scalability. The current EV/Sales ratio compares the total enterprise value, including net debt, to sales volume, allowing investors to determine the extent to which the asset is overvalued relative to the company's actual operational successes in production automation.